Condition: Leukemia · Relapse · Sponsor: First Affiliated Hospital of Zhejiang University
A single-arm trial to evaluate the effectiveness and safety of Blinatumomab and Donor Lymphocyte Infusion in maintenance therapy after allogeneic hematopoietic stem cell transplantation for high-risk Ph negative B cell acute lymphoblastic leukemia
This description comes directly from the study's public registry record.
Yi Luo, MD · 86-13666609126 · luoyijr@zju.edu.com
Luxin Yang, MD · 86-13588756650 · yangluxin2016@163.com
Always discuss trial participation with your own doctor first.
| First Affiliated Hospital of Zhejiang University | Hangzhou, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07105579